(Press-News.org) A new study from Karolinska Institutet shows that long-term exposure to air pollution contributes to millions of deaths in India. The research, published in The Lancet Planetary Health, emphasises the need for stricter air quality regulations in the country.
Air pollution consisting of particles smaller than 2.5 micrometres in diameter, PM2.5, can enter the lungs and bloodstream and is a major health risk in India. Researchers have now examined the link between these particles and mortality over a ten-year period. The study is based on data from 655 districts in India between 2009 and 2019.
“We found that every 10 microgram per cubic metre increase in PM2.5 concentration led to an 8.6 percent increase in mortality,” says Petter Ljungman, last author and researcher at the Institute of Environmental Medicine at Karolinska Institutet.
The research analysed the relationship between changes in air pollution levels and mortality. The results show that around 3.8 million deaths over the period can be linked to air pollution levels above India's own air quality guidelines of 40 micrograms per cubic metre.
When compared to the stricter guidelines recommended by the World Health Organisation (WHO) - only 5 micrograms per cubic metre - the figure rises to 16.6 million deaths. That's almost 25 per cent of all mortality during the study period.
The study also highlights that the entire population of India lives in areas where PM2.5 levels exceed WHO guidelines. This means that almost 1.4 billion people are exposed year after year to air pollution that can negatively affect health. In some regions, levels of up to 119 micrograms per cubic metre were measured, significantly higher than what both the WHO and India consider safe.
“The results show that current guidelines in India are not sufficient to protect health. Stricter regulations and measures to reduce emissions are of utmost importance,” said Petter Ljungman.
The Indian government has been running a national air pollution control programme since 2017 to improve air quality, but the study shows that PM2.5 concentrations have continued to increase in many areas. The researchers emphasise the importance of both reducing emissions locally and taking into account the long range of air pollution - PM2.5 particles can travel hundreds of kilometres.
“Our study provides evidence that can be used to create better air quality policies, both in India and globally,” says Petter Ljungman.
The study was funded by Formas. The study is a collaboration between researchers from universities in India, Sweden, USA, Israel and Italy.
Publication: ‘Estimating the effect of annual PM2-5 exposure on mortality in India: a difference-in-differences approach’, Suganthi Jaganathan, Massimo Stafoggia, Ajit Rajiva, Siddhartha Mandal, Shweta Dixit, Jeroen de Bont, Gregory A Wellenius, Kevin J Lane, Amruta Nori-Sarma, Itai Kloog, Dorairaj Prabhakaran, Poornima Prabhakaran, Joel Schwartz, Petter Ljungman, The Lancet Planetary Health, online December 11, 2024, doi: 10.1016/S2542-5196(24)00248-110
END
Air pollution in India linked to millions of deaths
2024-12-12
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Study finds widening inequalities in child vaccination rates across England
2024-12-12
Inequalities in childhood vaccination are widening in England, with uptake rates of five key vaccines consistently lower in young children living in areas of higher deprivation from 2019 to 2023, finds a study published by The BMJ today.
The researchers say vaccine uptake was below the World Health Organization’s recommended 95% target for all vaccinations studied and call for urgent action to strengthen systems for childhood vaccination.
Protecting children from vaccine preventable diseases ...
Investigation raises new concerns over landmark trial for top selling anti-platelet drug
2024-12-12
An investigation published by The BMJ today raises new concerns over the landmark clinical trial (PLATO) that was used to gain worldwide approval for the anti-platelet drug ticagrelor (Brilinta in the US and Brilique in Europe), manufactured by AstraZeneca.
Peter Doshi, senior editor at The BMJ, reveals new details that show problems in data reporting after obtaining primary PLATO trial records and unpublished data through a freedom of information request.
The PLATO trial was published in the New England Journal of Medicine (NEJM) in 2009. Assessing over 18,000 patients in 43 countries, investigators reported that ticagrelor ...
Making chemotherapy for Hodgkin lymphoma kinder to patients
2024-12-12
A simple change to the chemotherapy regimen for people with Hodgkin lymphoma could reduce the long-term health impacts that can result from treatment, according to researchers in Cambridge. The findings could lead to the national guidance on chemotherapy treatment for these patients being revised.
The study, published today in The Lancet Oncology was led by Cambridge University Hospitals NHS Foundation Trust (CUH) and the Wellcome Sanger Institute. It compares the lasting effects of two chemotherapy regimens used to treat Hodgkin lymphoma in younger adults. Hodgkin lymphoma ...
ACS study finds early-onset colorectal cancer cases surge globally
2024-12-12
ATLANTA, December 11, 2024 — A new study led by American Cancer Society (ACS) researchers shows that early-onset colorectal cancer (CRC) incidence rates are rising in 27 of 50 countries/territories worldwide, 20 of which have either exclusive or faster increases for early-onset disease. In 14 countries, including the United States, rates are increasing in young adults while stabilizing in those 50 years and older. The research is published today in the journal The Lancet Oncology.
“The ...
Fluctuating blood pressure tied to problems with thinking skills
2024-12-11
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, DECEMBER 11, 2024
MINNEAPOLIS – Older adults whose blood pressure fluctuates over time may be more likely to have problems with thinking and memory skills, according to a study published in the December 11, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The association was found in Black participants but not in white participants in the study.
The study does not prove that fluctuations in blood pressure cause problems with thinking skills; it only shows an association.
“These results suggest ...
Scientists find promising new target for antidepressants—in the gut
2024-12-11
Researchers have discovered new connections between the gut and brain that hold promise for more targeted treatments for depression and anxiety, and could help prevent digestive issues in children by limiting the transmission of antidepressants during pregnancy.
The study, published in the journal Gastroenterology, shows that increasing serotonin in the gut epithelium—the thin layer of cells lining the small and large intestines—improves symptoms of anxiety and depression in animal studies. The researchers also found ...
Antidepressants may act in gut to reduce depression and anxiety
2024-12-11
NEW YORK, NY (Dec. 11, 2024)--Most of us have experienced the effects of moods and emotions on our gastrointestinal tract, from “butterflies” in the stomach caused by nervousness to a loss of appetite when we’re feeling blue.
A new study in animals suggests that targeting antidepressant medications to cells in the gut could not only be an effective treatment of mood disorders like depression and anxiety but may also cause fewer cognitive, gastrointestinal, and behavioral side effects for patients and their children than current treatments.
“Antidepressants like Prozac and Zoloft that raise serotonin levels are important first-line ...
New PROSPECT-lung trial launches to advance treatment options for operable non-small cell lung cancer
2024-12-11
The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung cancer. The trial, which is the first to open through the newly formed National Cancer Institute (NCI) Clinical Trials Innovation Unit (CTIU), aims to evaluate the role of immunotherapy before and after surgery in patients with non-small cell lung cancer.
The PROSPECT-Lung trial is a large, multicenter trial developed and led by the Alliance for Clinical Trials in Oncology and the SWOG Cancer Research Network and conducted within the NIH-funded NCI National Clinical Trials Network (NCTN), ...
The Welch Foundation honors Rice’s Wang for pioneering contributions to sustainable energy solutions
2024-12-11
The Welch Foundation, one of the nation’s leading private funders of basic chemistry research, has awarded the 2025 Norman Hackerman Award in Chemical Research to Haotian Wang, an associate professor in the Department of Chemical and Biomolecular Engineering at Rice University. Wang is recognized for his groundbreaking contributions to carbon dioxide electrochemistry, which pave the way for sustainable energy solutions.
Wang’s innovative research focuses on harnessing the catalyst-electrolyte ...
Hospital payment caps could save millions of dollars for state employee health plans
2024-12-11
PROVIDENCE, R.I. [Brown University] — State employee health plans could have saved $7.1 billion nationwide by capping hospital payments at 200% of Medicare rates in 2022, a study led by researchers at the Brown University School of Public Health found.
“States are under growing budgetary pressure due to rising health care spending, primarily through increases in hospital and drug prices,” said study author Roslyn Murray, an assistant professor of health services, policy and practice ...